MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cognitive Mechanisms of Visual Dysfunction in Non-Demented PD Patients (PD-ND)

T. Lin, H. Gibler, S. Rapcsak (Tucson, AZ, USA)

Meeting: 2017 International Congress

Abstract Number: 79

Keywords: Cognitive dysfunction, Visuospatial deficits

Session Information

Date: Monday, June 5, 2017

Session Title: Parkinson's Disease: Non-Motor Symptoms

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To conduct a comprehensive assessment of visual processing in PD-ND, including tests of low-level vision sensitive to retinal pathology, high-level object/spatial vision reflecting ventral/dorsal visual pathway integrity, and to explore the relationship between executive dysfunction and visual impairment.

Background: Impairments in contrast sensitivity, color vision, attention, and eye movement control have been implicated as possible underlying causes of visual complaints in PD. Defective visual processing could have a negative impact on quality of life, but this topic has received relatively little attention in the literature.  

Methods: Thirty-five PD-ND and 41 healthy controls completed the study. Low-level vision was evaluated using a variable contrast acuity eye chart and the Farnsworth-Munsell color vision test. Ventral pathway tasks included reading single words, naming familiar objects/famous faces, and matching unfamiliar faces varying in single features vs. global configuration. Dorsal pathway/spatial exploration tasks included cancellation (lines, letters, shapes), King Devick test of rapid number naming, and locating objects/people in photographs. Frontal executive function was assessed by the anti-saccade test. Purdue pegboard and UPDRS were used to evaluate motor function.

Results: PD-NDs performed worse than controls on contrast sensitivity and color vision tests. On the ventral pathway tasks, PD-NDs were impaired in matching unfamiliar faces and performance correlated with reduced contrast sensitivity. PD-NDs were significantly slower on all dorsal pathway/spatial exploration tasks and showed enhanced sensitivity to task difficulty. Executive measure from anti-saccade test correlated with all dorsal pathway tasks even after controlling for bradykinesia. Executive dysfunction also correlated with color vision, but not with any of the ventral pathway tests.

Conclusions: Defective top-down executive control of attention in PD-ND contributes to impairments on dorsal pathway/spatial exploration tasks, but has little effect on ventral pathway/object recognition tasks. Ventral pathway deficits are only apparent in perceptually demanding tasks and may be attributable to reduced contrast sensitivity.  Farnsworth-Munsell test requires executive control of attention and is not an ideal test of color vision in patients with executive dysfunction.

To cite this abstract in AMA style:

T. Lin, H. Gibler, S. Rapcsak. Cognitive Mechanisms of Visual Dysfunction in Non-Demented PD Patients (PD-ND) [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/cognitive-mechanisms-of-visual-dysfunction-in-non-demented-pd-patients-pd-nd/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/cognitive-mechanisms-of-visual-dysfunction-in-non-demented-pd-patients-pd-nd/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley